The global market for Peptide API CDMO Services was valued at US$ 2342 million in the year 2024 and is projected to reach a revised size of US$ 6190 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Peptide API CDMO Services Market

Peptide API CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer comprehensive support for the development, manufacturing, and production of peptide active pharmaceutical ingredients (APIs). These services are essential for the pharmaceutical and biotechnology industries, facilitating the production of peptides for therapeutic purposes.

Global key players of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, Thermo Fisher, etc. The top five players hold a share over 54%. North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately. In terms of product type, GMP Services is the largest segment, occupied for a share of 72%. In terms of application, Commercial has a share about 75 percent.

This report aims to provide a comprehensive presentation of the global market for Peptide API CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide API CDMO Services.

The Peptide API CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide API CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide API CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide API CDMO Services Market Report

Report Metric	Details
Report Name	Peptide API CDMO Services Market
Accounted market size in year	US$ 2342 million
Forecasted market size in 2031	US$ 6190 million
CAGR	15.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	GMP Services Non-GMP Services
Segment by Application	Commercial Scientific Research Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, ScinoPharm, ChengDu ShengNuo Biotec, CBL, Piramal Pharma, CPC Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide API CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide API CDMO Services Market growing?

Ans: The Peptide API CDMO Services Market witnessing a CAGR of 15.1% during the forecast period 2025-2031.

What is the Peptide API CDMO Services Market size in 2031?

Ans: The Peptide API CDMO Services Market size in 2031 will be US$ 6190 million.

What is the market share of major companies in Peptide API CDMO Services Market?

Ans: The top five players hold a share over 54%.

What is the Peptide API CDMO Services Market share by region?

Ans: North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately.

What is the Peptide API CDMO Services Market share by type?

Ans: In terms of product type, GMP Services is the largest segment, occupied for a share of 72%.

Who are the main players in the Peptide API CDMO Services Market report?

Ans: The main players in the Peptide API CDMO Services Market are Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, ScinoPharm, ChengDu ShengNuo Biotec, CBL, Piramal Pharma, CPC Scientific

What are the Application segmentation covered in the Peptide API CDMO Services Market report?

Ans: The Applications covered in the Peptide API CDMO Services Market report are Commercial, Scientific Research, Other

What are the Type segmentation covered in the Peptide API CDMO Services Market report?

Ans: The Types covered in the Peptide API CDMO Services Market report are GMP Services, Non-GMP Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide API CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 GMP Services

1.2.3 Non-GMP Services

1.3 Market by Application

1.3.1 Global Peptide API CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Commercial

1.3.3 Scientific Research

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide API CDMO Services Market Perspective (2020-2031)

2.2 Global Peptide API CDMO Services Growth Trends by Region

2.2.1 Global Peptide API CDMO Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide API CDMO Services Historic Market Size by Region (2020-2025)

2.2.3 Peptide API CDMO Services Forecasted Market Size by Region (2026-2031)

2.3 Peptide API CDMO Services Market Dynamics

2.3.1 Peptide API CDMO Services Industry Trends

2.3.2 Peptide API CDMO Services Market Drivers

2.3.3 Peptide API CDMO Services Market Challenges

2.3.4 Peptide API CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide API CDMO Services Players by Revenue

3.1.1 Global Top Peptide API CDMO Services Players by Revenue (2020-2025)

3.1.2 Global Peptide API CDMO Services Revenue Market Share by Players (2020-2025)

3.2 Global Peptide API CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide API CDMO Services Revenue

3.4 Global Peptide API CDMO Services Market Concentration Ratio

3.4.1 Global Peptide API CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide API CDMO Services Revenue in 2024

3.5 Global Key Players of Peptide API CDMO Services Head office and Area Served

3.6 Global Key Players of Peptide API CDMO Services, Product and Application

3.7 Global Key Players of Peptide API CDMO Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide API CDMO Services Breakdown Data by Type

4.1 Global Peptide API CDMO Services Historic Market Size by Type (2020-2025)

4.2 Global Peptide API CDMO Services Forecasted Market Size by Type (2026-2031)

5 Peptide API CDMO Services Breakdown Data by Application

5.1 Global Peptide API CDMO Services Historic Market Size by Application (2020-2025)

5.2 Global Peptide API CDMO Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide API CDMO Services Market Size (2020-2031)

6.2 North America Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide API CDMO Services Market Size by Country (2020-2025)

6.4 North America Peptide API CDMO Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide API CDMO Services Market Size (2020-2031)

7.2 Europe Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide API CDMO Services Market Size by Country (2020-2025)

7.4 Europe Peptide API CDMO Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide API CDMO Services Market Size (2020-2031)

8.2 Asia-Pacific Peptide API CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide API CDMO Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide API CDMO Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide API CDMO Services Market Size (2020-2031)

9.2 Latin America Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide API CDMO Services Market Size by Country (2020-2025)

9.4 Latin America Peptide API CDMO Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide API CDMO Services Market Size (2020-2031)

10.2 Middle East & Africa Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide API CDMO Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide API CDMO Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bachem

11.1.1 Bachem Company Details

11.1.2 Bachem Business Overview

11.1.3 Bachem Peptide API CDMO Services Introduction

11.1.4 Bachem Revenue in Peptide API CDMO Services Business (2020-2025)

11.1.5 Bachem Recent Development

11.2 PolyPeptide

11.2.1 PolyPeptide Company Details

11.2.2 PolyPeptide Business Overview

11.2.3 PolyPeptide Peptide API CDMO Services Introduction

11.2.4 PolyPeptide Revenue in Peptide API CDMO Services Business (2020-2025)

11.2.5 PolyPeptide Recent Development

11.3 CordenPharma

11.3.1 CordenPharma Company Details

11.3.2 CordenPharma Business Overview

11.3.3 CordenPharma Peptide API CDMO Services Introduction

11.3.4 CordenPharma Revenue in Peptide API CDMO Services Business (2020-2025)

11.3.5 CordenPharma Recent Development

11.4 AmbioPharm

11.4.1 AmbioPharm Company Details

11.4.2 AmbioPharm Business Overview

11.4.3 AmbioPharm Peptide API CDMO Services Introduction

11.4.4 AmbioPharm Revenue in Peptide API CDMO Services Business (2020-2025)

11.4.5 AmbioPharm Recent Development

11.5 USV Peptides

11.5.1 USV Peptides Company Details

11.5.2 USV Peptides Business Overview

11.5.3 USV Peptides Peptide API CDMO Services Introduction

11.5.4 USV Peptides Revenue in Peptide API CDMO Services Business (2020-2025)

11.5.5 USV Peptides Recent Development

11.6 Thermo Fisher

11.6.1 Thermo Fisher Company Details

11.6.2 Thermo Fisher Business Overview

11.6.3 Thermo Fisher Peptide API CDMO Services Introduction

11.6.4 Thermo Fisher Revenue in Peptide API CDMO Services Business (2020-2025)

11.6.5 Thermo Fisher Recent Development

11.7 Bio Basic

11.7.1 Bio Basic Company Details

11.7.2 Bio Basic Business Overview

11.7.3 Bio Basic Peptide API CDMO Services Introduction

11.7.4 Bio Basic Revenue in Peptide API CDMO Services Business (2020-2025)

11.7.5 Bio Basic Recent Development

11.8 JPT

11.8.1 JPT Company Details

11.8.2 JPT Business Overview

11.8.3 JPT Peptide API CDMO Services Introduction

11.8.4 JPT Revenue in Peptide API CDMO Services Business (2020-2025)

11.8.5 JPT Recent Development

11.9 Genscript

11.9.1 Genscript Company Details

11.9.2 Genscript Business Overview

11.9.3 Genscript Peptide API CDMO Services Introduction

11.9.4 Genscript Revenue in Peptide API CDMO Services Business (2020-2025)

11.9.5 Genscript Recent Development

11.10 Chinese Peptide Company

11.10.1 Chinese Peptide Company Company Details

11.10.2 Chinese Peptide Company Business Overview

11.10.3 Chinese Peptide Company Peptide API CDMO Services Introduction

11.10.4 Chinese Peptide Company Revenue in Peptide API CDMO Services Business (2020-2025)

11.10.5 Chinese Peptide Company Recent Development

11.11 ScinoPharm

11.11.1 ScinoPharm Company Details

11.11.2 ScinoPharm Business Overview

11.11.3 ScinoPharm Peptide API CDMO Services Introduction

11.11.4 ScinoPharm Revenue in Peptide API CDMO Services Business (2020-2025)

11.11.5 ScinoPharm Recent Development

11.12 ChengDu ShengNuo Biotec

11.12.1 ChengDu ShengNuo Biotec Company Details

11.12.2 ChengDu ShengNuo Biotec Business Overview

11.12.3 ChengDu ShengNuo Biotec Peptide API CDMO Services Introduction

11.12.4 ChengDu ShengNuo Biotec Revenue in Peptide API CDMO Services Business (2020-2025)

11.12.5 ChengDu ShengNuo Biotec Recent Development

11.13 CBL

11.13.1 CBL Company Details

11.13.2 CBL Business Overview

11.13.3 CBL Peptide API CDMO Services Introduction

11.13.4 CBL Revenue in Peptide API CDMO Services Business (2020-2025)

11.13.5 CBL Recent Development

11.14 Piramal Pharma

11.14.1 Piramal Pharma Company Details

11.14.2 Piramal Pharma Business Overview

11.14.3 Piramal Pharma Peptide API CDMO Services Introduction

11.14.4 Piramal Pharma Revenue in Peptide API CDMO Services Business (2020-2025)

11.14.5 Piramal Pharma Recent Development

11.15 CPC Scientific

11.15.1 CPC Scientific Company Details

11.15.2 CPC Scientific Business Overview

11.15.3 CPC Scientific Peptide API CDMO Services Introduction

11.15.4 CPC Scientific Revenue in Peptide API CDMO Services Business (2020-2025)

11.15.5 CPC Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Chinese Peptide Company

ChengDu ShengNuo Biotec

List of Tables

Table 1. Global Peptide API CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of GMP Services

Table 3. Key Players of Non-GMP Services

Table 4. Global Peptide API CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Peptide API CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide API CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Peptide API CDMO Services Market Share by Region (2020-2025)

Table 8. Global Peptide API CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Peptide API CDMO Services Market Share by Region (2026-2031)

Table 10. Peptide API CDMO Services Market Trends

Table 11. Peptide API CDMO Services Market Drivers

Table 12. Peptide API CDMO Services Market Challenges

Table 13. Peptide API CDMO Services Market Restraints

Table 14. Global Peptide API CDMO Services Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Peptide API CDMO Services Market Share by Players (2020-2025)

Table 16. Global Top Peptide API CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide API CDMO Services as of 2024)

Table 17. Ranking of Global Top Peptide API CDMO Services Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Peptide API CDMO Services Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Peptide API CDMO Services, Headquarters and Area Served

Table 20. Global Key Players of Peptide API CDMO Services, Product and Application

Table 21. Global Key Players of Peptide API CDMO Services, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peptide API CDMO Services Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Peptide API CDMO Services Revenue Market Share by Type (2020-2025)

Table 25. Global Peptide API CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Peptide API CDMO Services Revenue Market Share by Type (2026-2031)

Table 27. Global Peptide API CDMO Services Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Peptide API CDMO Services Revenue Market Share by Application (2020-2025)

Table 29. Global Peptide API CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Peptide API CDMO Services Revenue Market Share by Application (2026-2031)

Table 31. North America Peptide API CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Peptide API CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Peptide API CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Peptide API CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Peptide API CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Peptide API CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Peptide API CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Peptide API CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Peptide API CDMO Services Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Peptide API CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Peptide API CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Peptide API CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Peptide API CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Peptide API CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Peptide API CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 46. Bachem Company Details

Table 47. Bachem Business Overview

Table 48. Bachem Peptide API CDMO Services Product

Table 49. Bachem Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 50. Bachem Recent Development

Table 51. PolyPeptide Company Details

Table 52. PolyPeptide Business Overview

Table 53. PolyPeptide Peptide API CDMO Services Product

Table 54. PolyPeptide Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 55. PolyPeptide Recent Development

Table 56. CordenPharma Company Details

Table 57. CordenPharma Business Overview

Table 58. CordenPharma Peptide API CDMO Services Product

Table 59. CordenPharma Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 60. CordenPharma Recent Development

Table 61. AmbioPharm Company Details

Table 62. AmbioPharm Business Overview

Table 63. AmbioPharm Peptide API CDMO Services Product

Table 64. AmbioPharm Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 65. AmbioPharm Recent Development

Table 66. USV Peptides Company Details

Table 67. USV Peptides Business Overview

Table 68. USV Peptides Peptide API CDMO Services Product

Table 69. USV Peptides Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 70. USV Peptides Recent Development

Table 71. Thermo Fisher Company Details

Table 72. Thermo Fisher Business Overview

Table 73. Thermo Fisher Peptide API CDMO Services Product

Table 74. Thermo Fisher Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 75. Thermo Fisher Recent Development

Table 76. Bio Basic Company Details

Table 77. Bio Basic Business Overview

Table 78. Bio Basic Peptide API CDMO Services Product

Table 79. Bio Basic Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 80. Bio Basic Recent Development

Table 81. JPT Company Details

Table 82. JPT Business Overview

Table 83. JPT Peptide API CDMO Services Product

Table 84. JPT Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 85. JPT Recent Development

Table 86. Genscript Company Details

Table 87. Genscript Business Overview

Table 88. Genscript Peptide API CDMO Services Product

Table 89. Genscript Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 90. Genscript Recent Development

Table 91. Chinese Peptide Company Company Details

Table 92. Chinese Peptide Company Business Overview

Table 93. Chinese Peptide Company Peptide API CDMO Services Product

Table 94. Chinese Peptide Company Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 95. Chinese Peptide Company Recent Development

Table 96. ScinoPharm Company Details

Table 97. ScinoPharm Business Overview

Table 98. ScinoPharm Peptide API CDMO Services Product

Table 99. ScinoPharm Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 100. ScinoPharm Recent Development

Table 101. ChengDu ShengNuo Biotec Company Details

Table 102. ChengDu ShengNuo Biotec Business Overview

Table 103. ChengDu ShengNuo Biotec Peptide API CDMO Services Product

Table 104. ChengDu ShengNuo Biotec Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 105. ChengDu ShengNuo Biotec Recent Development

Table 106. CBL Company Details

Table 107. CBL Business Overview

Table 108. CBL Peptide API CDMO Services Product

Table 109. CBL Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 110. CBL Recent Development

Table 111. Piramal Pharma Company Details

Table 112. Piramal Pharma Business Overview

Table 113. Piramal Pharma Peptide API CDMO Services Product

Table 114. Piramal Pharma Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 115. Piramal Pharma Recent Development

Table 116. CPC Scientific Company Details

Table 117. CPC Scientific Business Overview

Table 118. CPC Scientific Peptide API CDMO Services Product

Table 119. CPC Scientific Revenue in Peptide API CDMO Services Business (2020-2025) & (US$ Million)

Table 120. CPC Scientific Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Peptide API CDMO Services Picture

Figure 2. Global Peptide API CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide API CDMO Services Market Share by Type: 2024 VS 2031

Figure 4. GMP Services Features

Figure 5. Non-GMP Services Features

Figure 6. Global Peptide API CDMO Services Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Peptide API CDMO Services Market Share by Application: 2024 VS 2031

Figure 8. Commercial Case Studies

Figure 9. Scientific Research Case Studies

Figure 10. Other Case Studies

Figure 11. Peptide API CDMO Services Report Years Considered

Figure 12. Global Peptide API CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Peptide API CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Peptide API CDMO Services Market Share by Region: 2024 VS 2031

Figure 15. Global Peptide API CDMO Services Market Share by Players in 2024

Figure 16. Global Top Peptide API CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide API CDMO Services as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Peptide API CDMO Services Revenue in 2024

Figure 18. North America Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Peptide API CDMO Services Market Share by Country (2020-2031)

Figure 20. United States Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Peptide API CDMO Services Market Share by Country (2020-2031)

Figure 24. Germany Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Peptide API CDMO Services Market Share by Region (2020-2031)

Figure 32. China Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Peptide API CDMO Services Market Share by Country (2020-2031)

Figure 40. Mexico Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Peptide API CDMO Services Market Share by Country (2020-2031)

Figure 44. Turkey Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Peptide API CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Bachem Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 48. PolyPeptide Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 49. CordenPharma Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 50. AmbioPharm Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 51. USV Peptides Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 52. Thermo Fisher Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 53. Bio Basic Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 54. JPT Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 55. Genscript Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 56. Chinese Peptide Company Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 57. ScinoPharm Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 58. ChengDu ShengNuo Biotec Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 59. CBL Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 60. Piramal Pharma Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 61. CPC Scientific Revenue Growth Rate in Peptide API CDMO Services Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions